Hongcheng C. Shi

No. 180 In Fenglin Road
Zhongshan, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 296 publications

PET/CT in acute and time-sensitive non-oncological conditions: Current evidence, clinical applications, and emerging roles.

PET/CT in acute and time-sensitive non-oncological conditions: Current evidence, clinical applications, and emerging roles.

Journal: Seminars in nuclear medicine

Published: August 12, 2026

Delayed total-body [18F]FDG PET/CT demonstrates systemic vascular inflammation after concurrent chemoradiotherapy in patients with head and neck cancer.

Delayed total-body [18F]FDG PET/CT demonstrates systemic vascular inflammation after concurrent chemoradiotherapy in patients with head and neck cancer.

Journal: European journal of nuclear medicine and molecular imaging

Published: June 20, 2026

Intrathoracic herniated and obstructive colon tumor on 18F-FDG PET/CT.

Intrathoracic herniated and obstructive colon tumor on 18F-FDG PET/CT.

Journal: European journal of nuclear medicine and molecular imaging

Published: June 05, 2026

Amygdalar metabolic activity associated with cerebrovascular events and carotid-vertebral artery stenosis in takayasu arteritis.

Amygdalar metabolic activity associated with cerebrovascular events and carotid-vertebral artery stenosis in takayasu arteritis.

Journal: European journal of nuclear medicine and molecular imaging

Published: May 17, 2026

Is There an Added Value of Dual-Time-Point [68Ga]Ga-Fibroblast Activation Protein Inhibitor (FAPI) PET/CT in Differentiating Malignant and Benign Uptake Findings?

Is There an Added Value of Dual-Time-Point [68Ga]Ga-Fibroblast Activation Protein Inhibitor (FAPI) PET/CT in Differentiating Malignant and Benign Uptake Findings?

Journal: Cancers

Published: May 07, 2026

Detailed pharmacokinetic features of a novel bis-boron 18F-trifluoroborate acid in healthy volunteers: comparable and additional values of total-body PET-imaging-derived analysis.

Detailed pharmacokinetic features of a novel bis-boron 18F-trifluoroborate acid in healthy volunteers: comparable and additional values of total-body PET-imaging-derived analysis.

Journal: European journal of nuclear medicine and molecular imaging

Published: March 07, 2026

First Systematic Mapping of Non-Target [68Ga]Ga-DOTANOC Uptake Across Anatomical Sites and Etiologies.

First Systematic Mapping of Non-Target [68Ga]Ga-DOTANOC Uptake Across Anatomical Sites and Etiologies.

Journal: The British journal of radiology

Published: March 03, 2026

PET imaging of atherosclerotic plaques using the stabilin-2-targeted tracer 18F-S2P in preclinical models.

PET imaging of atherosclerotic plaques using the stabilin-2-targeted tracer 18F-S2P in preclinical models.

Journal: European journal of nuclear medicine and molecular imaging

Published: March 03, 2026

A workflow utilizing general-purpose large language models for efficient structuring and data mining of bone scintigraphy narratives.

A workflow utilizing general-purpose large language models for efficient structuring and data mining of bone scintigraphy narratives.

Journal: Scientific reports

Published: February 20, 2026

How organs react under fasting or glucose-insulin status: a self-controlled study using 18F-FDG total-body PET/CT.

How organs react under fasting or glucose-insulin status: a self-controlled study using 18F-FDG total-body PET/CT.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 14, 2026

Diagnostic utility of FAPI PET/CT in radioiodine-refractory thyroid cancer and TENIS syndrome: a systematic review.

Diagnostic utility of FAPI PET/CT in radioiodine-refractory thyroid cancer and TENIS syndrome: a systematic review.

Journal: Oncology reviews

Published: February 14, 2026

Pharmacokinetics and Dosimetry of [68Ga]Ga-PSMA-11 in Chinese Participants with Progressive Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Study.

Pharmacokinetics and Dosimetry of [68Ga]Ga-PSMA-11 in Chinese Participants with Progressive Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Study.

Journal: Cancer biotherapy & radiopharmaceuticals

Published: February 14, 2026

Showing 1-12 of 296

Last Updated: 09/26/2026